EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Interaction of endocrine therapy for breast cancer with APOE4 status on cognition over 5-year follow-up

Kathleen Van Dyk iD, Wanting Zhai, Tim A Ahles iD, James C Root iD, Jaeil Ahn iD, Ashley L Artese iD, Traci N Bethea iD, Harvey J Cohen, Martine Extermann iD, Deena Graham iD, Claudine Isaacs iD, Heather S L Jim iD und 10 weitere

JNCI Cancer Spectrum · 03.03.2026 · 10 (2)

DOI: 10.1093/jncics/pkag028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 17.03.2026. Verfasst von Kathleen Van Dyk und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry & Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los An…. Hauptthemen laut MEDLINE: Breast Neoplasms, Apolipoprotein E4, Cognition, Antineoplastic Agents, Hormonal. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, NCI NIH HHS, Georgetown Lombardi Comprehensive Cancer Center for support of the Biostatistics and Bioinformatics Resource and the Non-Therapeutic Shared Resource.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cognitive effects of breast cancer antiestrogen endocrine therapy are a salient concern for survivors, given the growing evidence that estrogen plays a role in late-life dementia risk. The APOE4 genotype has been linked with risk for cognitive difficulties, studied mainly in younger cancer survivors. We found that women aged 60+ with nonmetastatic breast cancer enrolled in the prospective Thinking and Living with Cancer study who underwent endocrine therapy had lower subjective (P = .06) and objective (P = .08) cognitive function than frequency-matched controls across time. At 5 years, however, women with breast cancer exposed to endocrine therapy and APOE4 carriers in particular exhibited lower learning and memory scores than other groups (P < .05). Our results suggest endocrine therapy may have long-term effects on cognitive function in women with breast cancer, particularly APOE4 carriers. Further characterization of genetic risk for long-term cognitive decline will be useful to inform survivorship care of older women.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsApolipoprotein E4CognitionAntineoplastic Agents, HormonalCognition DisordersHumansFemaleFollow-Up StudiesMiddle AgedAgedTime FactorsTamoxifenMemoryNitrilesAndrostadienesHeterozygote

Substanzen

Apolipoprotein E4Antineoplastic Agents, HormonalTamoxifenNitrilesAndrostadienes

Autor:innen und Institutionen

  • Department of Psychiatry & Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA, United States.
  • Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, United States.
  • City of Hope, Duarte, CA, United States.
  • Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC, United States.
  • Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Department of Exercise Science and Health Promotion, Charles E. Schmidt College of Science, Florida Atlantic University, Boca Raton, FL, United States.

ORCID-Profile: Kathleen Van Dyk, Tim A Ahles, James C Root, Jaeil Ahn, Ashley L Artese, Traci N Bethea, Martine Extermann, Deena Graham, Claudine Isaacs, Heather S L Jim, Brenna C McDonald, Zev M Nakamura, Sunita K Patel, Kelly E Rentscher, Andrew J Saykin, Brent J Small, Danielle B Tometich, Xingtao Zhou, Judith E Carroll, Jeanne S Mandelblatt

Förderung

  • NIA NIH HHS
  • NCI NIH HHS
  • Georgetown Lombardi Comprehensive Cancer Center for support of the Biostatistics and Bioinformatics Resource and the Non-Therapeutic Shared Resource
  • National Cancer Institute at the National Institutes of Health
  • Frank M. Ewing Foundation Endowed Chair of Hematology and Oncology
  • Thinking and Living cohort
  • National Institute on Aging

Zitieren

APA

Van Dyk, K., Zhai, W., Ahles, T. A., Root, J. C., Ahn, J., Artese, A. L., Bethea, T. N., Cohen, H. J., Extermann, M., Graham, D., Isaacs, C., Jim, H. S. L., McDonald, B. C., Nakamura, Z. M., Patel, S. K., Rentscher, K. E., Saykin, A. J., Small, B. J., Tometich, D. B., …, & Mandelblatt, J. S. (2026). Interaction of endocrine therapy for breast cancer with APOE4 status on cognition over 5-year follow-up. JNCI Cancer Spectrum, 10(2). https://doi.org/10.1093/jncics/pkag028

Vancouver

Van Dyk K, Zhai W, Ahles TA, Root JC, Ahn J, Artese AL, et al. Interaction of endocrine therapy for breast cancer with APOE4 status on cognition over 5-year follow-up. JNCI Cancer Spectrum. 2026;10(2). doi:10.1093/jncics/pkag028

BibTeX
@article{VanDyk2026,
  author = {Van Dyk, Kathleen and Zhai, Wanting and Ahles, Tim A and Root, James C and Ahn, Jaeil and Artese, Ashley L and Bethea, Traci N and Cohen, Harvey J and Extermann, Martine and Graham, Deena and Isaacs, Claudine and Jim, Heather S L and McDonald, Brenna C and Nakamura, Zev M and Patel, Sunita K and Rentscher, Kelly E and Saykin, Andrew J and Small, Brent J and Tometich, Danielle B and Zhou, Xingtao and Carroll, Judith E and Mandelblatt, Jeanne S},
  title = {Interaction of endocrine therapy for breast cancer with APOE4 status on cognition over 5-year follow-up},
  journal = {JNCI Cancer Spectrum},
  year = {2026},
  volume = {10},
  number = {2},
  doi = {10.1093/jncics/pkag028}
}
Kostenlos starten →